Alan J Tuchman insider trades: Synaptogenix (SNPX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | SNPX | ↓ Sell10b5-1 | 27,000 | $1.17 | $32K | Direct | Dec 20, 2022 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alan J Tuchman's insider trades
Alan J Tuchman is Chief Executive Officer at Synaptogenix (SNPX). Since Dec 16, 2022, Alan has reported no open-market purchases and 1 sale worth $32K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (7 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNPX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.